We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

55 hedge funds and large institutions have $14.1M invested in Korro Bio in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $13M → $14.1M (+$1.1M)

0.05% less ownership

Funds ownership: 0.5% → 0.45% (-0.05%)

5% less funds holding

Funds holding: 58 → 55 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
16
Closed
9
Calls
$563K
Puts
–
Net Calls
+$563K
Net Calls Change
+$8K

Top Buyers

1
WA
Wasatch Advisors
Utah
+$176K
2
GCP
GSA Capital Partners
United Kingdom
+$76K
3
Jane Street
Jane Street
New York
+$49.9K
4
Charles Schwab
Charles Schwab
California
+$47.4K
5
Brown Advisory
Brown Advisory
Maryland
+$40.2K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$505K
2
Federated Hermes
Federated Hermes
Pennsylvania
-$462K
3
Citadel Advisors
Citadel Advisors
Florida
-$159K
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$157K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.18M – – –
BlackRock
2
BlackRock
New York
$3.04M -$78.3K -771 -2%
Federated Hermes
3
Federated Hermes
Pennsylvania
$2.37M -$462K -4,554 -15%
WA
4
Wasatch Advisors
Utah
$1.35M +$176K +1,732 +13%
Renaissance Technologies
5
Renaissance Technologies
New York
$661K -$505K -4,975 -40%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$554K +$19.6K +193 +3%
Millennium Management
7
Millennium Management
New York
$461K -$67.6K -666 -11%
GCP
8
GSA Capital Partners
United Kingdom
$442K +$76K +749 +18%
State Street
9
State Street
Massachusetts
$222K – – –
E
10
Ergoteles
New York
$211K -$78.3K -771 -25%
BCM
11
Bridgeway Capital Management
Texas
$159K – – –
WPW
12
Waldron Private Wealth
Pennsylvania
$126K – – –
Northern Trust
13
Northern Trust
Illinois
$108K – – –
NSIM
14
North Star Investment Management
Illinois
$107K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$102K -$65.4K -644 -36%
Goldman Sachs
16
Goldman Sachs
New York
$100K -$40.8K -402 -26%
JIP
17
Jaffetilchin Investment Partners
Florida
$86K +$1.32K +13 +1%
NFC
18
Northeast Financial Consultants
Connecticut
$82K – – –
Citadel Advisors
19
Citadel Advisors
Florida
$79K -$159K -1,570 -64%
CAM
20
Cresset Asset Management
Illinois
$67K – – –
Morgan Stanley
21
Morgan Stanley
New York
$54K -$72.9K -718 -54%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$50K +$16.3K +161 +41%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$45K +$3.45K +34 +7%
Jane Street
24
Jane Street
New York
$44K +$49.9K +492 New
Charles Schwab
25
Charles Schwab
California
$42K +$47.4K +467 New
1
2 3

KRRO Hedge Fund Activity: Q3 2022 in Review

55 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2022, worth a combined $14.1M — up 8.5% from $13M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of KRRO and 6 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Wasatch Advisors, adding an estimated $176K. The largest seller was Renaissance Technologies, cutting an estimated $505K.

  • 55 institutional investors held Korro Bio (KRRO) as of Q3 2022, down from 58 in Q2 2022.
  • Funds reported $14.1M of Korro Bio stock for Q3 2022, up 8.5% quarter-over-quarter.
  • 6 funds opened new Korro Bio positions in Q3 2022 and 9 closed out, a net change of -3 holders.
  • The largest Korro Bio buyer in Q3 2022 was Wasatch Advisors, an estimated $176K added.
  • The largest Korro Bio seller in Q3 2022 was Renaissance Technologies, an estimated $505K sold.

Based on aggregated 13F filings for Q3 2022.